WallStreetZenWallStreetZen

NASDAQ: GTHX
G1 Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GTHX

Based on 4 analysts offering 12 month price targets for G1 Therapeutics Inc.
Min Forecast
$5.00+59.24%
Avg Forecast
$12.25+290.13%
Max Forecast
$19.00+505.1%

Should I buy or sell GTHX stock?

Based on 4 analysts offering ratings for G1 Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GTHX stock forecasts and price targets.

GTHX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-06
lockedlocked$00.00+00.00%2023-10-30
lockedlocked$00.00+00.00%2023-08-03
lockedlocked$00.00+00.00%2023-08-02

1 of 1

Forecast return on equity

Is GTHX forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is GTHX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

GTHX revenue forecast

What is GTHX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$80.5M+3.32%
Avg 2 year Forecast
$66.0M-15.29%
Avg 3 year Forecast
$109.1M+40.13%
GTHX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GTHX revenue growth forecast

How is GTHX forecast to perform vs Biotechnology companies and vs the US market?
Company
8.52%
Industry
34.65%
Market
7.68%
GTHX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GTHX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GTHX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GTHX$3.14$12.25+290.13%Strong Buy
OMER$2.57N/AN/A
VRCA$3.83$11.33+195.90%Buy
CLLS$2.97$8.50+186.20%Buy
ABOS$2.77$13.75+396.39%Strong Buy
View Top Biotech Stocks

G1 Therapeutics Stock Forecast FAQ

Is G1 Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: GTHX) stock is to Strong Buy GTHX stock.

Out of 4 analysts, 1 (25%) are recommending GTHX as a Strong Buy, 3 (75%) are recommending GTHX as a Buy, 0 (0%) are recommending GTHX as a Hold, 0 (0%) are recommending GTHX as a Sell, and 0 (0%) are recommending GTHX as a Strong Sell.

If you're new to stock investing, here's how to buy G1 Therapeutics stock.

What is GTHX's revenue growth forecast for 2023-2025?

(NASDAQ: GTHX) G1 Therapeutics's forecast annual revenue growth rate of 8.52% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is forecast to beat the US market's average forecast revenue growth rate of 7.68%.

G1 Therapeutics's revenue in 2023 is $77,888,000.On average, 4 Wall Street analysts forecast GTHX's revenue for 2023 to be $4,171,963,732, with the lowest GTHX revenue forecast at $4,134,014,166, and the highest GTHX revenue forecast at $4,249,107,111. On average, 4 Wall Street analysts forecast GTHX's revenue for 2024 to be $3,420,645,281, with the lowest GTHX revenue forecast at $2,858,141,472, and the highest GTHX revenue forecast at $3,769,553,173.

In 2025, GTHX is forecast to generate $5,658,477,253 in revenue, with the lowest revenue forecast at $3,338,732,284 and the highest revenue forecast at $7,126,430,741.

What is GTHX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GTHX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is GTHX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year GTHX price target, the average GTHX price target is $12.25, with the highest GTHX stock price forecast at $19.00 and the lowest GTHX stock price forecast at $5.00.

On average, Wall Street analysts predict that G1 Therapeutics's share price could reach $12.25 by Dec 6, 2024. The average G1 Therapeutics stock price prediction forecasts a potential upside of 290.13% from the current GTHX share price of $3.14.

What is GTHX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GTHX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.